Introduction:
Varicella-Zoster Virus VZV is a DNA virus belonging to the herpes virus family, responsible for two clinical conditions. The primary infection generates varicella (chickenpox). Secondary infection also known as reactivation of latent VZV induces shingle [1].
Recently, following the massive administration of COVID-19 vaccines to a large population, several adverse events following immunization AEFI have been observed that were not initially mentioned in the safety data sheet of these vaccines or detected in clinical trials prior to its marketing [2]. Post-marketing, sporadic case reports and a series of VZV reactivations have been reported [3].
In this study, we aimed to present and analyze the characteristics of VZV reactivation cases after COVID-19 vaccination.